Ellen Lefever
Förmögenhet: - $ per 2026-06-30
Förmögenhet: - $ per 2026-06-30
Ellen Lefever is currently General Counsel at AgomAb Therapeutics NV since 2021.
Formerly, Ms. Lefever was Deputy General Counsel at Galapagos NV from 2019 to 2021.
Education includes graduate degrees from Katholieke Universiteit Leuven and Stanford Law School.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-18 | 0 ( -.--% ) | - $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| AGOMAB THERAPEUTICS NV | Generell Rådgivare | 2021-07-01 |
| Företag | Position | Slut |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Generell Rådgivare | 2019-04-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Galapagos NV
Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford Law School
Stanford Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AgomAb Therapeutics NV
AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån